Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling human embryo adhesion using a microfluidic platform.

Science advances·2026
Same author

Fibrosis Process Activation in Patients with Acute Cardiac Rejection: A Novel Noninvasive Diagnostic Approach.

Biomedicines·2026
Same author

Multimodal Patient-Specific Identification of Atrial Flutter Circuits From ECG Time Series Using Explainable Machine Learning.

IEEE journal of translational engineering in health and medicine·2026
Same author

Chamber-Specific Structural, Fibrotic, and Molecular Remodeling of the Heart in Experimental Metabolic Syndrome.

International journal of molecular sciences·2026
Same author

Eighteen Years of Measuring Treatment Satisfaction in Clinical Research: A Scoping Review of Instruments and Contexts of Use.

Patient preference and adherence·2026
Same author

DNA as a quantum system in evolution.

PloS one·2026

Related Experiment Video

Updated: Mar 2, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.4K

Hydrogen Sulfide Improves Cardiomyocyte Function in a Cardiac Arrest Model.

Nahuel Aquiles Garcia1, Javier Moncayo-Arlandi1,2, Alejandro Vazquez1

  • 1Mixed Unit for Cardiovascular Repair, Institute of Sanitary Research La Fe-Príncipe Felipe Research Center, Valencia, Spain.

Annals of Transplantation
|May 10, 2017
PubMed
Summary

Hydrogen sulfide donor GYY4137 protects heart cells from damage during nutrient starvation and cardiac arrest. Supplementing cardioplegia solutions with GYY4137 reduces apoptosis and preserves heart function, suggesting improved cardiac surgery outcomes.

More Related Videos

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

8.6K
Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

894

Related Experiment Videos

Last Updated: Mar 2, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.4K
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

8.6K
Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

894

Area of Science:

  • Cardiology
  • Biochemistry
  • Cell Biology

Background:

  • Cardioplegic arrest is crucial for cardiac surgery, with ongoing research into enhanced cardio-protective formulations.
  • Hydrogen sulfide (H2S) is recognized for its significant cardio-protective signaling properties.
  • Investigating H2S donors in conjunction with cardioplegia aims to improve surgical outcomes.

Purpose of the Study:

  • To evaluate the cardio-protective effects of the hydrogen sulfide donor GYY4137 in HL-1 cardiac cells under nutrient-starved conditions.
  • To assess the efficacy of GYY4137 when added to Cardi-Braun® and del Nido cardioplegia solutions in a rat heart model.
  • To determine if GYY4137 can mitigate apoptosis, preserve energy levels, and reduce oxidative stress in cardiac tissue during cardioplegic arrest.

Main Methods:

  • HL-1 cells were pre-treated with GYY4137 under nutrient-starved conditions to assess apoptosis and ATP content.
  • Ex vivo Langendorff perfused rat hearts were used to test GYY4137-supplemented Cardi-Braun® and del Nido cardioplegia solutions.
  • Measurements included caspase-3 levels, ATP content, S-adenosylmethionine/S-adenosylhomocysteine ratio, and heart beating parameters.

Main Results:

  • GYY4137 pre-treatment significantly reduced apoptosis (28%) and maintained ATP content in nutrient-starved HL-1 cells.
  • Cardioplegia solutions with GYY4137 significantly decreased caspase-3 levels and preserved ATP content in perfused rat hearts.
  • GYY4137 supplementation reduced oxidative stress markers and preserved heart rate and inter-beat intervals in del Nido solution.

Conclusions:

  • GYY4137 preconditioning enhances cellular energy status and attenuates cardiomyocyte apoptosis in vitro.
  • Adding GYY4137 to cardioplegia solutions protects against apoptosis, ATP depletion, and oxidative stress in heart tissue.
  • GYY4137 shows potential to improve cardioplegia efficacy and restore electrophysiological function post-cardiac arrest during surgery.